Home News and Analysis Deals & Exits Engrail Therapeutics nabs $32m Series A

Engrail Therapeutics nabs $32m Series A

San Diego-based Engrail Therapeutics, a drug developer, has raised $32 million in Series A financing.

18 June 2020

San Diego-based Engrail Therapeutics, a drug developer, has raised $32 million in Series A financing. Nan Fung Life Sciences led the round.

Register now

Get limited access to our industry news, analysis and data, plus regular email updates

Email address

First name

first name

Last name

last name

Organisation

Country Phone number Job title

Job Title

To register, please review and accept our terms and conditions and privacy notice. I accept: sourceRegistration

Not for publication, email or dissemination